lapatinib (brand name: Tykerb)
A drug that works against HER2-positive breast cancers by blocking the ability of the cancer cells to receive chemical signals that tell the cells to grow. It is a type of targeted therapy that belongs to a group of drugs called HER2 (human epidermal receptor 2) inhibitors.
Read more about lapatinib (brand name: Tykerb).
